# Chunyu Mobile Health

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/chunyu-mobile-health

- Industry: Healthcare IT
- Headquarters: Beijing, China
- Website: www.chunyuyisheng.com
- Total disclosed funding: $54M
- Latest round: Series E (Sep 10, 2020)
- Investors on record: 7

## About

Based in Beijing, China and established in 2011, Chunyu Mobile Health operates as a mobile healthcare Q&A (question and answer) service provider that offers healthcare information, health consulting and online medical services. The company won the Best ICT Project Excellence Award in China at the Asian Hospital Management Awards. It has cooperated with Tencent, Baidu, Bayer, Pfizer, GSK, and other enterprises. In November 2011, the company launched its main product Chunyu Doctor, APP version. In March 2024, Chunyu Mobile Health raised USD 213 million in strategic investment.

Through cooperation with hospitals and physician groups, the company provides user self-diagnosis, health counseling, health information, disease knowledge base and doctor-patient interactive exchange services. The company's core business includes Chunyu Digital Internet Hospital, Chunyu Health Management Services, and Chunyu Popular Science Content Dissemination, etc. Its main product is an online healthcare platform. The platform provides Internet medical services such as online consultation, family doctor, Internet hospital, video consultation, etc. As of May 2022, Chunyu Doctor has cumulatively served over 400 million patients.

Chunyu Mobile Health will focus on product innovation, optimizing its medical service model, improving its physician management system, and expanding its pharmaceutical e-commerce partnerships.

## Funding rounds

- Series E, Sep 10, 2020 — Beijing Sogou Information Service Co., Ltd., InnoVision Capital
- Series C, Aug 19, 2014, $50M — BlueRun Ventures, China International Capital Corporation, Pavilion Capital, Crestvalue
- Series B, Mar 1, 2013, $1M — BAI Capital
- Series A, Nov 1, 2011, $3M — BlueRun Ventures

## Investors

- BlueRun Ventures (https://capitalatlas.ai/funds/bluerun-ventures) — Series A, Series C
- BAI Capital (https://capitalatlas.ai/funds/bai-capital) — Series B
- China International Capital Corporation (https://capitalatlas.ai/funds/china-international-capital-corporation) — Series C
- Pavilion Capital — Series C
- Crestvalue (https://capitalatlas.ai/funds/crestvalue) — Series C
- Beijing Sogou Information Service Co., Ltd. — Series E
- InnoVision Capital (https://capitalatlas.ai/funds/innovision-capital) — Series E
